Principal Investigators


Maria Eriksdotter

Institution


Karolinska Institute

Contact information of lead PI


Country


Sweden

Title of project or programme


Towards Neurotrophic therapes in Alzheimer's disease

Source of funding information


The Swedish Brain Foundation

Total sum awarded (Euro)


€ 108,814

Start date of award


01/07/2015

Total duration of award in years


2.5

Keywords


Research Abstract


The overall goal of this program is to explore novel ways to target key pathological mechanisms in AD by direct central nervous system (CNS) targeting regenerative growth
factor signaling, using both local delivery of the two growth factors NGF and BDNF as well as small-molecule allosteric modulators of growth factor signaling aiming at improving
cognitive function. Leveraging the functional selectivity of allosteric modulators of NGF and BDNF provides a potential opportunity to develop agents that selectively target NGF and
BDNF signaling pathways and transportation. The concept will be investigated by cell and animal models. The project brings together a multidisciplinary team of scientists from different disciplines and the necessary resources and models to move novel findings towards clinical translation.

Further information available at:

Export as PDF